UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 128

Sortiert nach

Pembrolizumab for the first-line treatment of non-small cell lung cancer

Expert opinion on biological therapy, 2018-10, Vol.18 (10), p.1015-1021

2018

Link zum Volltext

Verfügbarkeit prüfen

A Phase II Study of Trastuzumab Emtansine in HER2-Positive Non–Small Cell Lung Cancer

Journal of thoracic oncology, 2018-02, Vol.13 (2), p.273-279

2018

Link zum Volltext

Verfügbarkeit prüfen

The effect and safety of immune checkpoint inhibitor rechallenge in non-small cell lung cancer

Japanese journal of clinical oncology, 2019-08, Vol.49 (8), p.762-765

2019

Link zum Volltext

Verfügbarkeit prüfen

Immune checkpoint inhibitor efficacy and safety in older non-small cell lung cancer patients

Japanese journal of clinical oncology, 2020-12, Vol.50 (12), p.1447-1453

2020

Link zum Volltext

Verfügbarkeit prüfen

SY20-3 Development of treatment for HER2 or EGFR exon 20 insertion mutation-driven NSCLC

Annals of oncology, 2022-07, Vol.33, p.S444

Ninomiya, Kiichiro

2022

Link zum Volltext

Verfügbarkeit prüfen

Congestive Heart Failure During Osimertinib Treatment for Epidermal Growth Factor Receptor (EGFR)-mutant Non-small Cell Lung Cancer (NSCLC)

Internal Medicine, 2017/08/15, Vol.56(16), pp.2195-2197

2017

Link zum Volltext

Verfügbarkeit prüfen

MET or NRAS amplification is an acquired resistance mechanism to the third-generation EGFR inhibitor naquotinib

Scientific reports, 2018-01, Vol.8 (1), p.1955-11, Article 1955

2018

Link zum Volltext

Verfügbarkeit prüfen

A suspected case of rocuronium–sugammadex complex-induced anaphylactic shock after cesarean section

Journal of anesthesia, 2017-02, Vol.31 (1), p.148-151

2017

Link zum Volltext

Verfügbarkeit prüfen

Significance of re-biopsy of histological tumor samples in advanced non-small-cell lung cancer in clinical practice

International journal of clinical oncology, 2019-01, Vol.24 (1), p.41-45

2019

Link zum Volltext

Verfügbarkeit prüfen

Utility of immune checkpoint inhibitors in non‐small‐cell lung cancer patients with poor performance status

Cancer science, 2020-10, Vol.111 (10), p.3739-3746

2020

Link zum Volltext

Verfügbarkeit prüfen

Recent treatment strategy for advanced squamous cell carcinoma of the lung in Japan

International journal of clinical oncology, 2019-05, Vol.24 (5), p.461-467

2019

Link zum Volltext

Verfügbarkeit prüfen

Beneficial effect of erlotinib and trastuzumab emtansine combination in lung tumors harboring EGFR mutations

Biochemical and biophysical research communications, 2020-11, Vol.532 (3), p.341-346

2020

Link zum Volltext

Verfügbarkeit prüfen

SHP2 Inhibition Enhances the Effects of Tyrosine Kinase Inhibitors in Preclinical Models of Treatment-naïve ALK-, ROS1- , or EGFR -altered Non-small Cell Lung Cancer

Molecular cancer therapeutics, 2021-09, Vol.20 (9), p.1653-1662

2021

Link zum Volltext

Verfügbarkeit prüfen

Fulminant Myocarditis for Non-small-cell Carcinoma of the Lung with Nivolumab and Ipilimumab Plus Chemotherapy

Internal Medicine, 2023/05/01, Vol.62(9), pp.1319-1322

2023

Link zum Volltext

Verfügbarkeit prüfen

Influence of age on the efficacy of immune checkpoint inhibitors in advanced cancers: a systematic review and meta-analysis

Acta oncologica, 2020-03, Vol.59 (3), p.249-256

2020

Link zum Volltext

Verfügbarkeit prüfen

A randomized trial of sodium alginate prevention of esophagitis in LA-NSCLC receiving chemoradiotherapy: OLCSG1401

Supportive care in cancer, 2021-09, Vol.29 (9), p.5237-5244

2021

Link zum Volltext

Verfügbarkeit prüfen

Re-administration of osimertinib in osimertinib-acquired resistant non-small-cell lung cancer

Lung cancer (Amsterdam, Netherlands), 2019-06, Vol.132, p.54-58

2019

Link zum Volltext

Verfügbarkeit prüfen

Severe Cytokine Release Syndrome and Immune Effector Cell-associated Neurotoxicity Syndrome in a Man Receiving Immune Checkpoint Inhibitors for Lung Cancer

Internal medicine (Tokyo, 1992), 2024-05, Vol.63 (9), p.1261-1267

2024

Link zum Volltext

Verfügbarkeit prüfen

Pulmonary Aspergilloma and Allergic Bronchopulmonary Aspergillosis Following the 2018 Heavy Rain Event in Western Japan

Internal Medicine, 2022/02/01, Vol.61(3), pp.379-383

2022

Link zum Volltext

Verfügbarkeit prüfen

Marginal Zone Lymphoma and Lung Adenocarcinoma with an EGFR Exon 19 E746-S752del Mutation in a Patient with IgG4-related Disease

Internal Medicine, 2021/09/01, Vol.60(17), pp.2831-2837

2021

Link zum Volltext

Verfügbarkeit prüfen

A Prompt Diagnosis and Treatment of a Case of Nuclear Protein of the Testis Carcinoma Characterized by a Bronchial Lesion and High Serum Alpha-fetoprotein Level Following Genomic Testing

Internal Medicine, 2024, pp.2938-23

2024

Link zum Volltext

Verfügbarkeit prüfen

A Unique Case of Sarcoid-associated Myelopathy Accompanied by Lung Cancer

Internal Medicine, 2023/12/01, Vol.62(23), pp.3531-3535

2023

Link zum Volltext

Verfügbarkeit prüfen

Identification of targetable kinases in idiopathic pulmonary fibrosis

Respiratory research, 2022-02, Vol.23 (1), p.20-20, Article 20

2022

Link zum Volltext

Verfügbarkeit prüfen

A novel osimertinib-resistant human lung adenocarcinoma cell line harbouring mutant EGFR and activated IGF1R

Japanese journal of clinical oncology, 2021-05, Vol.51 (6), p.956-965

2021

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 128

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(101)
Mit Volltextzugriff
(120)

Publikationsform

Artikel
(123)
Berichte
(5)

Sprache

Englisch
(108)
Japanisch
(54)

Erscheinungsjahr

n.n

Thema

Science & Technology
(67)
Life Sciences & Biomedicine
(66)
Humans
(51)
Oncology
(45)
Female
(36)
Lung Cancer
(33)
Male
(27)
Aged
(26)
Lung Neoplasms - Drug Therapy
(24)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(20)
Middle Aged
(20)
Cancer Research
(18)
Respiratory System
(18)
Lung Neoplasms - Genetics
(17)
Mutation
(17)
Carcinoma, Non-Small-Cell Lung - Genetics
(15)
Chemotherapy
(15)
Lung Neoplasms - Pathology
(14)
Medicine
(14)
Adult
(13)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Internal Medicine
(12)
Haigan. Lung Cancer
(8)
Journal Of Clinical Oncology
(8)
Cancer Research
(7)
The Japanese Journal Of Antibiotics
(7)
Clinical Lung Cancer
(6)
Haigan
(5)
肺癌
(5)
Cancer Science
(4)
Hinyokika Kiyo. Acta Urologica Japonica
(4)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Pembrolizumab for the first-line treatment of non-small cell lung cancer

VEGFR2 blockade augments the effects of tyrosine kinase inhibitors by inhibiting angiogenesis and oncogenic signaling in oncogene‐driven non‐small‐cell lung cancers

A Phase II Study of Trastuzumab Emtansine in HER2-Positive Non–Small Cell Lung Cancer

The effect and safety of immune checkpoint inhibitor rechallenge in non-small cell lung cancer

Immune checkpoint inhibitor efficacy and safety in older non-small cell lung cancer patients

SY20-3 Development of treatment for HER2 or EGFR exon 20 insertion mutation-driven NSCLC

Congestive Heart Failure During Osimertinib Treatment for Epidermal Growth Factor Receptor (EGFR)-mutant Non-small Cell Lung Cancer (NSCLC)

MET or NRAS amplification is an acquired resistance mechanism to the third-generation EGFR inhibitor naquotinib

A suspected case of rocuronium–sugammadex complex-induced anaphylactic shock after cesarean section

Significance of re-biopsy of histological tumor samples in advanced non-small-cell lung cancer in clinical practice

Utility of immune checkpoint inhibitors in non‐small‐cell lung cancer patients with poor performance status

Recent treatment strategy for advanced squamous cell carcinoma of the lung in Japan

Beneficial effect of erlotinib and trastuzumab emtansine combination in lung tumors harboring EGFR mutations

SHP2 Inhibition Enhances the Effects of Tyrosine Kinase Inhibitors in Preclinical Models of Treatment-naïve ALK-, ROS1- , or EGFR -altered Non-small Cell Lung Cancer

Fulminant Myocarditis for Non-small-cell Carcinoma of the Lung with Nivolumab and Ipilimumab Plus Chemotherapy

Influence of age on the efficacy of immune checkpoint inhibitors in advanced cancers: a systematic review and meta-analysis

A randomized trial of sodium alginate prevention of esophagitis in LA-NSCLC receiving chemoradiotherapy: OLCSG1401

Re-administration of osimertinib in osimertinib-acquired resistant non-small-cell lung cancer

Severe Cytokine Release Syndrome and Immune Effector Cell-associated Neurotoxicity Syndrome in a Man Receiving Immune Checkpoint Inhibitors for Lung Cancer

Pulmonary Aspergilloma and Allergic Bronchopulmonary Aspergillosis Following the 2018 Heavy Rain Event in Western Japan

Marginal Zone Lymphoma and Lung Adenocarcinoma with an EGFR Exon 19 E746-S752del Mutation in a Patient with IgG4-related Disease

A Prompt Diagnosis and Treatment of a Case of Nuclear Protein of the Testis Carcinoma Characterized by a Bronchial Lesion and High Serum Alpha-fetoprotein Level Following Genomic Testing

A Unique Case of Sarcoid-associated Myelopathy Accompanied by Lung Cancer

Identification of targetable kinases in idiopathic pulmonary fibrosis

A novel osimertinib-resistant human lung adenocarcinoma cell line harbouring mutant EGFR and activated IGF1R

Suchergebnisse filtern